Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Cariprazine: Preliminary Phase IIb data

Preliminary data from a U.S. Phase IIb trial in 389 patients showed that the low dose of cariprazine

Read the full 181 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE